Byrne, Kate F. and Pal, Ajay and Curtin, James F. and Stephens, John C. and Kinsella, Gemma K. (2021) G-protein-coupled receptors as therapeutic targets for glioblastoma. Drugs Discovery Today, 26 (12). pp. 2858-2870. ISSN 1359-6446

Preview

Download (1MB) | Preview

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumour in adults. Treatments include surgical resection, radiotherapy, and chemotherapy. Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately needed. In this review, we focus on recent advances in G-protein-coupled receptor (GPCR) targets. To date, the most promising targets are the chemokine, cannabinoid, and dopamine receptors, but future work should further examine the melanocortin receptor-4 (MC4R), adhesion, lysophosphatidic acid (LPA) and smoothened (Smo) receptors to initiate new drug-screening strategies and targeted delivery of safe and effective GBM therapies.

Item Type:	Article
Additional Information:	Cite as: Byrne, K.F., Pal, A., Curtin, J.F., Stephens, J.C. & Kinsella, G.K. 2021, "G-protein-coupled receptors as therapeutic targets for glioblastoma", Drug discovery today, vol. 26, no. 12, pp. 2858-2870.
Keywords:	G-protein-coupled receptors; (GPCRs); Glioblastoma multiforme (GBM);
Academic Unit:	Faculty of Science and Engineering > Chemistry Faculty of Science and Engineering > Research Institutes > Human Health Institute
Item ID:	17447
Identification Number:	https://doi.org/10.1016/j.drudis.2021.07.008
Depositing User:	Dr John Stephens
Date Deposited:	17 Aug 2023 14:43
Journal or Publication Title:	Drugs Discovery Today
Publisher:	Elsevier
Refereed:	Yes
URI:	Publisher
Use Licence:	This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

Repository Staff Only(login required)

Item control page

Downloads

Origin of downloads